Replies to post #3436 on Phio Pharmaceuticals Corp (PHIO)

[Titan V]

Let's hope these were the reasons why Geert only did a RS to the $2 range.

[Inoviorulez]

It's good to see that nobody is shorting Rxi as much anymore, as I stated before they no longer have Tang Capital to help them short the stock. In addition, the float is much smaller now, and smart money knows not to short a low float stock. Especially one with so much news on the horizon. If all the pieces of phase 2 scar data, phase 1/2 retinal scar data, and samcyprone scar data fall into place I expect $10 to $15 afterwards